Nivolumab in Heavily Pretreated Metastatic Gastric Cancer Patients: Real-Life Data from a Western Population.
Angelica PetrilloGiuseppe TirinoFederica Zito MarinoLuca PompellaRosalaura SabettaIacopo PanareseAnnalisa PappalardoMarianna CaterinoAnna VentrigliaMaria Maddalena LaterzaFloriana MorgilloMichele OrdituraFortunato CiardielloRenato FrancoFerdinando De VitaPublished in: OncoTargets and therapy (2020)
Nivolumab is feasible and effective in Western patients with mGC. Further investigation is urgently needed also in non-Asians.